Found: 53
Select item for more details and to access through your institution.
Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells.
- Published in:
- Oncogene, 2010, v. 29, n. 35, p. 4885, doi. 10.1038/onc.2010.243
- By:
- Publication type:
- Article
abl oncogene expression in non-Hodgkin lymphomas: Correlation to histological differentiation and clinical status.
- Published in:
- International Journal of Cancer, 1988, v. 42, n. 4, p. 529, doi. 10.1002/ijc.2910420410
- By:
- Publication type:
- Article
PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER1/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial.
- Published in:
- British Journal of Surgery, 2021, v. 108, n. 3, p. 308, doi. 10.1093/bjs/znaa089
- By:
- Publication type:
- Article
Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.
- Published in:
- Oncogene, 2015, v. 34, n. 42, p. 5341, doi. 10.1038/onc.2014.450
- By:
- Publication type:
- Article
APOBEC3 signature mutations in chronic lymphocytic leukemia.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 9, p. 1929, doi. 10.1038/leu.2014.160
- By:
- Publication type:
- Article
Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 4, p. 954, doi. 10.1038/leu.2014.37
- By:
- Publication type:
- Article
Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 12, p. 2508, doi. 10.1038/leu.2012.147
- By:
- Publication type:
- Article
Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 9, p. 1452, doi. 10.1038/leu.2011.111
- By:
- Publication type:
- Article
Multidimensional scaling as a tool for analysing quality of life data.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Normative data for functional assessment of cancer therapy: General Scale and its use for the interpretation of quality of life scores in cancer survivors.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
Multimodal Therapy in Life-Threatening Cerebral Lupus erythematosus: The Benefit of Cerebrospinal Fluid Pheresis.
- Published in:
- International Archives of Allergy & Immunology, 1995, v. 107, n. 4, p. 592, doi. 10.1159/000237105
- By:
- Publication type:
- Article
Necrotizing vasculitis associated with hepatitis C virus infection: successful treatment of vasculitis with interferon-alpha despite persistence of mixed cryoglobulinemia.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts.
- Published in:
- Cell Death & Differentiation, 2001, v. 8, n. 10, p. 1014, doi. 10.1038/sj.cdd.4400914
- By:
- Publication type:
- Article
Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells.
- Published in:
- Cell Death & Differentiation, 2000, v. 7, n. 9, p. 834, doi. 10.1038/sj.cdd.4400719
- By:
- Publication type:
- Article
Raltegravir in pregnancy: a case series presentation.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Raltegravir in pregnancy: a case series presentation.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer.
- Published in:
- British Journal of Cancer, 2007, v. 97, n. 8, p. 1021, doi. 10.1038/sj.bjc.6604011
- By:
- Publication type:
- Article
Advantages of Taylor‐Couette Flow for Multiphase Operations in the Taylor‐Couette Disc Contactor.
- Published in:
- Chemie Ingenieur Technik (CIT), 2022, v. 94, n. 9, p. 1219, doi. 10.1002/cite.202255209
- By:
- Publication type:
- Article
BRECADD IS NON‐INFERIOR TO EBEACOPP IN PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: EFFICACY RESULTS OF THE GHSG PHASE III HD21 TRIAL.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 881, doi. 10.1002/hon.3196_LBA5
- By:
- Publication type:
- Article
Imatinib‐induced complete and long‐term sustained remission in chemotherapy‐resistant systemic ALK‐positive anaplastic large cell lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 504, doi. 10.1002/hon.3164_372
- By:
- Publication type:
- Article
Ibrutinib (Ibr) dose modification for management of early cardiac adverse events in patients with chronic lymphocytic leukemia: Pooled analysis of 7 clinical trials.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 461, doi. 10.1002/hon.3164_340
- By:
- Publication type:
- Article
Toxicities at one year follow‐up in patients with advanced stage classical Hodgkin Lymphoma: results from the randomized phase III HD21 trial by the German Hodgkin Study Group.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 363, doi. 10.1002/hon.3164_261
- By:
- Publication type:
- Article
Impact of PET‐2 guided treatment de‐escalation on time‐to‐recovery from cancer‐related fatigue in advanced stage Hodgkin Lymphoma: results from the GHSG HD18 study.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 355, doi. 10.1002/hon.3164_255
- By:
- Publication type:
- Article
ZANUBRUTINIB (ZANU) VERSUS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT‐NAïVE (TN) CLL/SLL: EXTENDED FOLLOW‐UP OF THE SEQUOIA STUDY.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 235, doi. 10.1002/hon.3163_154
- By:
- Publication type:
- Article
IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 135, doi. 10.1002/hon.95_2629
- By:
- Publication type:
- Article
SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R<sup>2</sup>‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.93_2629
- By:
- Publication type:
- Article
UNMAINTAINED REMISSION AFTER DISCONTINUATION OF KINASE INHIBITOR TREATEMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: AN OBSERVATIONAL COHORT.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 218, doi. 10.1002/hon.33_2630
- By:
- Publication type:
- Article
IBRUTINIB DECREASES OBINUTUZUMAB‐INDUCED SECRETION OF CYTOKINES ASSOCIATED WITH INFUSION‐RELATED REACTIONS IN PATIENTS WITH CLL: ANALYSIS FROM THE ILLUMINATE STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 210, doi. 10.1002/hon.27_2630
- By:
- Publication type:
- Article
IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R‐CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 135, doi. 10.1002/hon.95_2629
- By:
- Publication type:
- Article
SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R<sup>2</sup>‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.93_2629
- By:
- Publication type:
- Article
UNMAINTAINED REMISSION AFTER DISCONTINUATION OF KINASE INHIBITOR TREATEMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: AN OBSERVATIONAL COHORT.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 218, doi. 10.1002/hon.33_2630
- By:
- Publication type:
- Article
IBRUTINIB DECREASES OBINUTUZUMAB‐INDUCED SECRETION OF CYTOKINES ASSOCIATED WITH INFUSION‐RELATED REACTIONS IN PATIENTS WITH CLL: ANALYSIS FROM THE ILLUMINATE STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 210, doi. 10.1002/hon.27_2630
- By:
- Publication type:
- Article
EBEACOPP WITH OR WITHOUT RITUXIMAB IN INTERIM-PET-POSITIVE ADVANCED-STAGE HODGKIN LYMPHOMA: UPDATED RESULTS OF THE INTERNATIONAL, RANDOMIZED PHASE 3 GHSG HD18 TRIAL.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 65, doi. 10.1002/hon.2437_52
- By:
- Publication type:
- Article
Sicherheit der Immunsuppressiva.
- Published in:
- Zeitschrift für Rheumatologie, 2012, v. 71, n. 5, p. 420, doi. 10.1007/s00393-012-0990-z
- By:
- Publication type:
- Article
Expression of leucocyte function--associated antigen--1 and 7F7--antigen, an adhesion molecule related to intercellular adhesion molecule--1 (ICAM--1) in non--Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour.
- Published in:
- Clinical & Experimental Immunology, 1989, v. 77, n. 2, p. 234
- By:
- Publication type:
- Article
Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of follicular structures.
- Published in:
- Clinical & Experimental Immunology, 1986, v. 64, n. 2, p. 423
- By:
- Publication type:
- Article
IMMUNOHISTOLOGY FOR QUANTIFICATION OF NORMAL BONE MARROW LYMPHOCYTE SUBSETS.
- Published in:
- British Journal of Haematology, 1989, v. 73, n. 4, p. 576, doi. 10.1111/j.1365-2141.1989.tb00307.x
- By:
- Publication type:
- Article
Growth fraction of tumour cells and infiltrationdensity with natural killer-like (HNK1<sup>+</sup>) cells in non-Hodgkin lymphomas.
- Published in:
- British Journal of Haematology, 1986, v. 62, n. 2, p. 293, doi. 10.1111/j.1365-2141.1986.tb02932.x
- By:
- Publication type:
- Article
Erratum to: Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group For Medical Tumor Therapy
- Published in:
- 2014
- By:
- Publication type:
- Correction notice
Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 2, p. 267, doi. 10.1007/s00277-013-1966-z
- By:
- Publication type:
- Article
Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.
- Published in:
- British Journal of Cancer, 2015, v. 112, n. 8, p. 1405, doi. 10.1038/bjc.2015.98
- By:
- Publication type:
- Article
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
- Published in:
- British Journal of Cancer, 2014, v. 111, n. 11, p. 2051, doi. 10.1038/bjc.2014.504
- By:
- Publication type:
- Article
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
- Published in:
- British Journal of Cancer, 2014, v. 111, n. 1, p. 55, doi. 10.1038/bjc.2014.277
- By:
- Publication type:
- Article
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2− breast cancer patients.
- Published in:
- British Journal of Cancer, 2013, v. 109, n. 12, p. 2959, doi. 10.1038/bjc.2013.671
- By:
- Publication type:
- Article
The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.
- Published in:
- British Journal of Cancer, 2013, v. 109, n. 3, p. 589, doi. 10.1038/bjc.2013.367
- By:
- Publication type:
- Article
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
- Published in:
- British Journal of Cancer, 2013, v. 108, n. 7, p. 1408, doi. 10.1038/bjc.2013.114
- By:
- Publication type:
- Article